Geisslinger G - Search Results

1

Alterations in the hippocampal endocannabinoid system in diet-induced obese mice.

Massa F, Mancini G, Schmidt H, Steindel F, Mackie K, Angioni C, Oliet SH, Geisslinger G, Lutz B. Massa F, et al. Among authors: geisslinger g. J Neurosci. 2010 May 5;30(18):6273-81. doi: 10.1523/JNEUROSCI.2648-09.2010. J Neurosci. 2010. PMID: 20445053 Free PMC article.

2

Selective cyclooxygenase-2 inhibitor. Pharmacology and state of knowledge following commercial availability.

Schmidt H, Geisslinger G. Schmidt H, et al. Among authors: geisslinger g. Schmerz. 2001 Jun;15(3):207-19. doi: 10.1007/s004820170026. Schmerz. 2001. PMID: 11810359 Review. No abstract available.

3

[Current post-marketing information. Effects and adverse effects of celecoxib].

Schmidt H, Geisslinger G. Schmidt H, et al. Among authors: geisslinger g. Pharm Unserer Zeit. 2002;31(2):180-7. doi: 10.1002/1615-1003(200203)31:2<180::AID-PAUZ180>3.0.CO;2-W. Pharm Unserer Zeit. 2002. PMID: 11977454 Review. German. No abstract available.

4

The influence of inhibition of probenecid sensitive transporters on the central nervous system (CNS) uptake and the antinociceptive activity of morphine-6-glucuronide in rats.

Lötsch J, Schmidt R, Vetter G, Schmidt H, Skarke C, Niederberger E, Geisslinger G, Tegeder I. Lötsch J, et al. Among authors: geisslinger g. Neurosci Lett. 2002 Aug 30;329(2):145-8. doi: 10.1016/s0304-3940(02)00618-3. Neurosci Lett. 2002. PMID: 12165398

5

Benefit-risk assessment of rofecoxib in the treatment of osteoarthritis.

Schmidt H, Woodcock BG, Geisslinger G. Schmidt H, et al. Among authors: geisslinger g. Drug Saf. 2004;27(3):185-96. doi: 10.2165/00002018-200427030-00003. Drug Saf. 2004. PMID: 14756580 Review.

6

LC-MS/MS-analysis of sphingosine-1-phosphate and related compounds in plasma samples.

Schmidt H, Schmidt R, Geisslinger G. Schmidt H, et al. Among authors: geisslinger g. Prostaglandins Other Lipid Mediat. 2006 Dec;81(3-4):162-70. doi: 10.1016/j.prostaglandins.2006.09.003. Epub 2006 Oct 10. Prostaglandins Other Lipid Mediat. 2006. PMID: 17085324

7

Consequences of altered eicosanoid patterns for nociceptive processing in mPGES-1-deficient mice.

Brenneis C, Coste O, Schmidt R, Angioni C, Popp L, Nusing RM, Becker W, Scholich K, Geisslinger G. Brenneis C, et al. Among authors: geisslinger g. J Cell Mol Med. 2008 Apr;12(2):639-48. doi: 10.1111/j.1582-4934.2007.00110.x. J Cell Mol Med. 2008. PMID: 18419601 Free PMC article.

8

Antinociceptive activity of the S1P-receptor agonist FTY720.

Coste O, Pierre S, Marian C, Brenneis C, Angioni C, Schmidt H, Popp L, Geisslinger G, Scholich K. Coste O, et al. Among authors: geisslinger g. J Cell Mol Med. 2008 Jun;12(3):995-1004. doi: 10.1111/j.1582-4934.2008.00160.x. J Cell Mol Med. 2008. PMID: 18494940 Free PMC article.

9

Dimethylcelecoxib inhibits prostaglandin E2 production.

Wobst I, Schiffmann S, Birod K, Maier TJ, Schmidt R, Angioni C, Geisslinger G, Grösch S. Wobst I, et al. Among authors: geisslinger g. Biochem Pharmacol. 2008 Jul 1;76(1):62-9. doi: 10.1016/j.bcp.2008.04.008. Epub 2008 Apr 24. Biochem Pharmacol. 2008. PMID: 18508034

10

The selective COX-2 inhibitor celecoxib modulates sphingolipid synthesis.

Schiffmann S, Sandner J, Schmidt R, Birod K, Wobst I, Schmidt H, Angioni C, Geisslinger G, Grösch S. Schiffmann S, et al. Among authors: geisslinger g. J Lipid Res. 2009 Jan;50(1):32-40. doi: 10.1194/jlr.M800122-JLR200. Epub 2008 Aug 18. J Lipid Res. 2009. PMID: 18711209 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

609 results

Search Page

Filters